Navigation Links
VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
Date:11/12/2007

statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond VIA's control and which could materially affect actual results, levels of activity, performance or achievements.

Factors that may cause actual results to differ materially from current expectations include, but are not limited to:

* our ability to obtain necessary financing;

* our ability to control our operating expenses;

* our ability to recruit and enroll patients for the CEA, ACS and FDG-

PET clinical trials;

* our ability to successfully complete our clinical trials of VIA-2291

on expected timetables and the outcomes of such clinical trials;

* the results of our clinical trials, including without limitation,

with respect to the safety and efficacy of VIA-2291;

* the outcome of any legal proceedings;

* our ability to obtain necessary FDA approvals;

* our ability to successfully commercialize VIA-2291;

* our ability to obtain and protect our intellectual property related

to our product candidates;

* our potential for future growth and the development of our product

pipeline;

* our ability to form and maintain collaborative relationships to

develop and commercialize our product candidates;

* general economic and business conditions; and

* the other risks described under the heading "Risk Factors" in our

Quarterly Report on Form 10-Q for the quarter ended June 30, 2007 on

file with the SEC and in Amendment No. 3 to our Registration

Statement on Form S-3, filed with the SEC October 15, 2007.

All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... AtheroNova Inc. (OTCQB: AHRO) today announced that the ... under Chapter 11 of the U.S. Bankruptcy Code in the ... , Santa Ana division (the "Bankruptcy ... are expected to be jointly administered. The Company ... sale process, for all or substantially all of its assets ...
(Date:3/3/2015)... Cambridge Semantics, the leading provider of smart data ... it has been named to KMWorld’s 2015 list of ... , To create the list each year, KMWorld assembles ... who identify organizations dedicated to the true value of ... right people at the right time. , “The ...
(Date:3/3/2015)... , March 3, 2015  Johnson & Johnson ... South San Francisco (JLABS @SSF), a ... South San Francisco, Calif. The ... up to 50 startups from across the healthcare spectrum ... The first resident startups have been ...
(Date:3/3/2015)... , March 3, 2015 /PRNewswire/ - BioAmber Inc. ... producing sustainable chemicals, today announced it has initiated commissioning ... located in Sarnia, Ontario , Canada.  ... take approximately five months, with the facility being in ... to be completed in two months and it is ...
Breaking Biology Technology:AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 2AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 4Cambridge Semantics Named to KMWorld’s 2015 ‘100 Companies That Matter in Knowledge Management’ 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 4Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 5BioAmber Begins Commissioning of Sarnia Commercial Plant 2BioAmber Begins Commissioning of Sarnia Commercial Plant 3
... Neptune Technologies &,Bioressources Inc. ("Neptune") (NASDAQ.NEPT - ... a dynamic new Scientific Advisory Board (the,"Advisory ... Neptune believes that the combined knowledge and ... Board will significantly contribute to Neptune,s,scientifically driven ...
... and NEEDHAM, Massachusetts, October 15 /PRNewswire-FirstCall/,-- Oridion ... at this week,s American,Society of Anesthesiologists Annual ... Microstream(R) Monitoring System (MSM(TM)), powered by the,Bernoulli(R) ... technology for,continuous central station monitoring, is the ...
... Data on Successful Use of New PGD Technique to ... Society for Reproductive Medicine (ASRM) Annual Meeting -, ... Pre-natal Screening, for Spontaneous Pregnancies as well as ... and LIVINGSTON, N.J., Oct. 15 Empire,Genomics, developing high ...
Cached Biology Technology:Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board 2Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board 3Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety 2Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety 3Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety 4Empire Genomics and Reprogenetics Join Forces to Improve Preimplantation Genetic Diagnosis (PGD) 2Empire Genomics and Reprogenetics Join Forces to Improve Preimplantation Genetic Diagnosis (PGD) 3
(Date:2/5/2015)... Conn. , Jan. 26, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... new corporate website ( http://www.nxt-id.com/ ) as part of ... smart wallet. The Company launched its new consumer website ... Gino Pereira , CEO of NXT-ID said, "Our new ...
(Date:2/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6lngtl/global_biometrics ... "Global Biometrics Market (2014-2020): Market Forecast By Technologies, ... to their offering. , In ... is anticipated to overtake North America ... spending towards IT security, government biometric based projects ...
(Date:1/22/2015)... ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform its shareholders ... Washington,s Department of Licensing, in the United States, awarded ... for driver,s licenses and identification cards to its subsidiary, Valid ... start in January 2015, with enrollment and card production starting ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... power electric cars have problems. They take a long ... to drive long distances. They don,t allow drivers to ... at the University of California, Riverside,s Bourns College of ... in an environmentally friendly way to solve some of ...
... have dramatically improved survival for infants born prior to ... However, up to 50 percent of these infants ... require extensive health care, educational and psychosocial community resources ... reliable method to identify those infants who will go ...
... segregating household sleeping arrangements, according to a new study ... researchers found malaria eradication related more to household size ... professor Ross McKitrick and two Finnish professors, Larry and ... below four persons, malaria extermination is much more likely. ...
Cached Biology News:Pressure cooking to improve electric car batteries 2Women & Infants earns $3 million grant from National Institutes of Health 2Control malaria by segmenting sleeping arrangements 2
...
... of the members of the GPCR family ... splicing--which has important implications for drug research. ... classical expression profiling and at the same ... of the gene that are expressed in ...
... ExonHit can design custom microarrays to detect ... list. Proprietary algorithms are used to ... from high quality, spliced cDNAs aligned to ... in a custom SpliceArray is profiled with ...
... an important role in the regulation of ... death. Splice variants have been reported that ... defined apoptotic pathways. With Apoptosis and Cell ... classical expression profiling and at the same ...
Biology Products: